Related Experiment Videos
[Bullous pemphigoid in an infant]
Beatriz Sousa1, Alberto Mota, Helder Morgado
1Serviço de Pediatria, Hospital de S. João, Faculdade de Medicina, Porto.
Acta Medica Portuguesa
|October 7, 2005
Summary
Bullous pemphigoid, a rare autoimmune blistering disease, was diagnosed in a six-month-old infant. Treatment with corticosteroids led to a favorable outcome in this exceptional pediatric case.
Area of Science:
- Dermatology
- Immunology
- Pediatrics
Background:
- Bullous pemphigoid is an acquired autoimmune blistering disease primarily affecting the elderly.
- It is exceptionally rare in infants, with only ten cases previously documented in medical literature.
Observation:
- A previously healthy six-month-old infant presented with a six-day history of erythematous, vesico-bullous cutaneous lesions.
- Clinical presentation suggested an autoimmune blistering disorder.
Findings:
- Histopathological examination and direct immunofluorescence studies confirmed the diagnosis of bullous pemphigoid.
- The infant exhibited characteristic immunopathological findings of the disease.
Implications:
- This case expands the limited literature on infantile bullous pemphigoid, highlighting its occurrence in very young children.
- Successful treatment with systemic and topical corticosteroids demonstrates therapeutic efficacy in this pediatric demographic.
- Further research into the specific triggers and long-term outcomes of infantile bullous pemphigoid is warranted.